Back to All Events

ESMO West


  • The Antlers 4 South Cascade Avenue Colorado Springs, CO, 80903 United States (map)
Register For Free Today
Become An Exhibitor

In-Person Access Only | 8.0 CE/CME Credits & MOC Points

All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.

The European Society for Medical Oncology (ESMO) and Total Health partnered to expand access in the US to the latest developments in the management of cancer from our European colleagues. This free conference covers highlights from the ESMO Congress 2025, equipping healthcare providers with the latest strategies to improve clinical practice and treatment outcomes in cancer care. The accredited meeting will be hosted as an in-person conference. 

 

Conference Agenda
Saturday, November 1, 2025

8:00 AM
Coffee and Exhibits

8:30 AM
Program Chair Welcome
Thierry Alcindor, MD, MSc | Dana-Farber Cancer Institute (Program Co-Chair)

8:40 AM
Colorectal Cancer 
Christopher Lieu, MD | University of Colorado 

9:10 AM
Non-Colorectal Cancer
Thierry Alcindor, MD, MSc | Dana-Farber Cancer Institute (Program Co-Chair)

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Taiho - LONSURF® + bevacizumab for the Treatment of 3L Metastatic Colorectal Cancer
Saurin Chokshi, MD | The University of Tennessee Health Science Center

10:40 AM
Small Cell Lung Cancer
Kyle Concannon, MD| University of Colorado

11:10 AM
Non-Small Cell Lung Cancer
Urs Weber, MD | University of Colorado

11:40 AM
Lunch and Exhibits

11:55 AM
Non- CME Lunch - Stemline - Upon 1L Progression, Discover the Path Forward With ORSERDU for Patients With ESR1m
Marcela Mazo Canola, MD | University Of Texas Health Science Center At San Antonio San Antonio TX

12:40 PM
Housekeeping and Survey

12:50 PM
Head and Neck Cancer
Ezra Cohen, MD | UC San Diego 

1:20 PM
Leukemia
Christine McMahon, MD | University of Colorado

1:50 PM
Lymphoma

Steven Bair, MD| UC Health

2:10 PM
Networking Reception

4:10 PM
ADJOURN

Sunday, November 2, 2025

8:00 AM
Coffee and Exhibits

8:30 AM
Program Chair Welcome
Eric Liu, MD | Rocky Mountain Cancer Center (Program Co-Chair)

8:40 AM
Prostate Cancer
Mike Lattanzi, MD | US Oncology 

9:10 AM
Non-Prostate Cancer
Mike Lattanzi, MD | US Oncology 

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Gilead - Offering an ADC Treatment for Patients With Pretreated HR+/HER2- mBC and mTNBC
Chaitali Nangia, MD | Hoag Medical Group

10:40 AM
Melanomas
Gary Doolittle, MD | The University of Kansas Cancer Center 

11:10 AM
Sarcomas and Rare Cancers
Abhijeet Kumar, MD | University of Arizona 

11:40 AM
Lunch and Exhibits

11:55 PM
Non-CME Lunch - Pfizer - Clinical Case Reviews: Treatment of a Broad Range of Patients With HR+/HER2- Metastatic Breast Cancer
David Page, MD | Providence Portland Medical Center

12:40 PM
PRIME Survey 

12:50 PM
Part One - Unlocking Precision: Genetic Testing and Counseling Essentials for Breast Cancer Care
 
Anthony Elias, MD (Moderator) | University of Colorado & Lee Schwartzberg, MD | Renown Cancer Center

1:20 PM
Part Two - Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment
Anthony Elias, MD (Moderator) | University of Colorado & Lee Schwartzberg, MD | Renown Cancer Center


1:50 PM
Early-Stage Breast Cancer

Anthony Elias, MD | University of Colorado

2:20 PM
Metastatic Breast Cancer
Lee Schwartzberg, MD | Renown Cancer Center

2:50 PM
Fertility Preservation in Cancer
Julie Messina, PA-C | Rocky Mountain Cancer Center

3:10 PM
Neuroendocrine Tumors
Eric Liu, MD | Rocky Mountain Cancer Center (Program Co-Chair)

3:30 PM
ADJOURN

Agenda Subject To Change. All times are MST.

 
    • Examine scientific advances that further enhance knowledge of cancer biology and pathogenesis

    • Review recent and emerging data from key studies in clinical cancer research

    • Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of people with cancer

    • Implement clinical and scientific strategies designed to improve the quality of cancer care, as appropriate

    • Effectively communicate with colleagues and with patients regarding advances in clinical oncology science

    • Identify and utilize tools for cancer risk assessment and risk reduction based on the best available evidence

  • In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Nurses (ANCC) Credit Designation

    Amedco LLC designates this activity for a maximum of 8.0 ANCC contact hours.

    Physicians (ACCME) Credit Designation

    Amedco LLC designates this live activity for a maximum of 8.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

    Amedco LLC designates this activity for a maximum of 8.0 knowledge-based CPE contact hours.

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

    American Board of Internal Medicine (ABIM) MOC Credit

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.

    • Free registration for all healthcare providers

    • Expert sessions that present the most clinically relevant data, research, and clinical strategies

    • Enduring video content for watching at your leisure

    • Real-time discussion and debate

    • Networking with peers, colleagues, and medical professionals

    • Access to the latest industry information and resources

    • Catered meals through-out the program

 
Follow for Updates
Previous
Previous
November 1

Multidisciplinary Head and Neck Cancer Symposium

Next
Next
November 1

ESMO East